PACTR201807337809744Not yet recruiting未知
Effect of transjugular intrahepatic portosystemic shunt insertion in hepatic patients on the haemodynamics
ational Liver Institute0 sites40 target enrollmentStarted: July 30, 2018Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 13 Year(s) to 18 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Adult patients scheduled for elective TIPS procedure with stable haemodynamic condition and acceptable echocardiography.
Exclusion Criteria
- •Cardiac co-morbidity.
- •Severe coagulation disorder.
- •Renal failure.
- •Neoplastic disease.
Investigators
Similar Trials
Recruiting
Not Applicable
Influence of the transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients on sarcopeniaMuscle wasting and atrophy, not elsewhere classified, multiple sitesM62.59K74.6Other and unspecified cirrhosis of liverDRKS00024507niversitätsklinikum Freiburg100
Withdrawn
Not Applicable
The effects of Transjugular Intrahepatic Portosystemic Shunt placement on von Willebrand factor levels in plasma of patients with cirrhosis and portal hypertension.NL-OMON38711niversitair Medisch Centrum Groningen16
Completed
Not Applicable
The impact of trans-jugular intrahepatic portosystemic shunts on muscle mass in chronic liver disease.portal hypertensionsarcopeniaTrans-jugular intrahepatic portosystemic shuntOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disorderscirrhosisACTRN12619000081112Department of Gastroenterology and Hepatology, Austin Health14
Completed
Not Applicable
Covered transjugular intrahepatic portosystemic stent shunt versus optimised medical treatment for the secondary prevention of variceal bleeding in cirrhosisISRCTN16334693Individual sponsor (Germany)186
Active, not recruiting
Not Applicable
Covered Transjugular Intrahepatic Portosystemic Stent Shunt versus Optimized medical Treatment for the Secondary Prevention of Variceal Bleeding in Cirrhosisliver cirrhosisesophageal (variceal) bleedingEUCTR2005-003557-27-DEDean of the Medical Faculty (University of Bonn)